Radio waves plus targeted drug aim to extend life in tough-to-treat colon cancer

NCT ID NCT07130903

Recruiting now Disease control Sponsor: Barbara Ann Karmanos Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a non-invasive device that delivers low-level radio waves (AM RF EMF) to the targeted drug fruquintinib can help people with metastatic colorectal cancer that has stopped responding to other treatments live longer. About 102 participants will receive both treatments. The main goal is to see if this combination improves overall survival and is safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC COLORECTAL ADENOCARCINOMA

Contacts and locations

Locations

Karmanos Cancer Institute
RECRUITING

Detroit, Michigan, 48201, United States
Karmanos Cancer Institute at McLaren Bay Region
RECRUITING

Bay City, Michigan, 48706, United States
Karmanos Cancer Institute at McLaren Clarkston
RECRUITING

Clarkston, Michigan, 48346, United States
Karmanos Cancer Institute at McLaren Flint
RECRUITING

Flint, Michigan, 48532, United States
Karmanos Cancer Institute at McLaren Greater Lansing
RECRUITING

Lansing, Michigan, 48910, United States
Karmanos Cancer Institute at McLaren Lapeer Region
RECRUITING

Lapeer, Michigan, 48446, United States
Karmanos Cancer Institute at McLaren Macomb
RECRUITING

Macomb, Michigan, 48043, United States
Karmanos Cancer Institute at McLaren Northern Michigan, Petoskey
RECRUITING

Petoskey, Michigan, 49770, United States
Karmanos Cancer Institute at McLaren Port Huron
RECRUITING

Port Huron, Michigan, 48060, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.